Karyopharm to present at 42nd annual j.p. morgan healthcare conference

Newton, mass. , jan. 3, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate at the 42nd annual j.p.
KPTI Ratings Summary
KPTI Quant Ranking